Literature DB >> 10172079

Obesity and insurance risk: the insurance industry's viewpoint.

I M Baird1.   

Abstract

Obesity is regarded by insurance companies as a substantial risk for both life and disability policies. This risk increases proportionally with the degree of obesity. Mortality statistics for life insurance were the earliest indicator that the cost of obesity to the individual was a decreased life span and increased illness, particularly that affecting the cardiovascular and musculoskeletal systems. The prevalence of coronary heart disease rises with increases in the body mass index in both men and women. Cigarette smoking greatly augments these risks in both sexes. Hypertension and diabetes are very common in obese persons and add further to the risks of vascular disease. Abdominal obesity (when the abdominal girth measured round the umbilicus exceeds the maximum measurement round the hips) is correlated with the risk of cardiac disease and stroke, independently of bodyweight. Insurance companies consider abdominal obesity as unfavourable and rate it accordingly. Obesity (even that of moderate degree) greatly increases the chances of disability due to cardiovascular disease or musculoskeletal illness. In one study of 51 522 adult Finns, 25% of disability pensions in women were found to result directly from obesity. Obesity causes increased health expenditure, decreased life span and productivity, and premature retirement. Insurance companies are compelled to build these risks into their policies. However, because the excess mortality occurs late in mild to moderate obesity, some companies may minimise this risk for life policies that mature early.

Entities:  

Mesh:

Year:  1994        PMID: 10172079     DOI: 10.2165/00019053-199400051-00013

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  16 in total

1.  A prospective study of obesity and risk of coronary heart disease in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; B Rosner; R R Monson; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

2.  Regional obesity as a health hazard in men--prospective studies.

Authors:  B Larsson
Journal:  Acta Med Scand Suppl       Date:  1988

3.  Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.

Authors: 
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  Effects of being overweight.

Authors:  A L Stewart; R H Brook
Journal:  Am J Public Health       Date:  1983-02       Impact factor: 9.308

5.  Impact of age on weight goals.

Authors:  R Andres; D Elahi; J D Tobin; D C Muller; L Brant
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

6.  Health implications of obesity. National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

7.  Prevalence and correlates of lower extremity arterial disease in elderly women.

Authors:  M T Vogt; J A Cauley; L H Kuller; S B Hulley
Journal:  Am J Epidemiol       Date:  1993-03-01       Impact factor: 4.897

8.  Risk of disability and mortality due to overweight in a Finnish population.

Authors:  A Rissanen; M Heliövaara; P Knekt; A Reunanen; A Aromaa; J Maatela
Journal:  BMJ       Date:  1990-10-13

9.  Body weight and coronary heart disease mortality: an analysis in relation to age and smoking habit. 15 years follow-up data from the Whitehall Study.

Authors:  A P Fitzgerald; R J Jarrett
Journal:  Int J Obes Relat Metab Disord       Date:  1992-02

10.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

View more
  1 in total

Review 1.  Socioeconomic consequences of obesity: the effect of obesity on the individual.

Authors:  G Enzi
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.